We are live on
!
Find out more
Edwards Lifesciences
1,219 hedge funds and large institutions have $34.2B invested in Edwards Lifesciences in 2023 Q3 according to their latest regulatory filings, with 109 funds opening new positions, 430 increasing their positions, 466 reducing their positions, and 152 closing their positions.
New
Increased
Maintained
Reduced
Closed
89% more call options, than puts
Call options by funds: $292M | Put options by funds: $154M
0.64% less ownership
Funds ownership: 81.63% → 80.99% (-0.64%)
8% less repeat investments, than reductions
Existing positions increased: 430 | Existing positions reduced: 466
5% less funds holding
Funds holding: 1,278 → 1,219 (-59)
27% less capital invested
Capital invested by funds: $46.6B → $34.2B (-$12.4B)
28% less first-time investments, than exits
New positions opened: 109 | Existing positions closed: 152
68% less funds holding in top 10
Funds holding in top 10: 19 → 6 (-13)
Holders
1,219
Holders Change
-59
Holders Change %
-4.62%
% of All Funds
19.35%
Holding in Top 10
6
Holding in Top 10 Change
-13
Holding in Top 10 Change %
-68.42%
% of All Funds
0.1%
New
109
Increased
430
Reduced
466
Closed
152
Calls
$292M
Puts
$154M
Net Calls
+$138M
Net Calls Change
+$83.1M
Top Buyers
Top Sellers
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$566M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$223M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$200M |
| 4 |
Holocene Advisors
New York
|
-$152M |
| 5 |
Amundi
Paris,
France
|
-$120M |
